UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 04/2011, Volume 364, Issue 17, pp. 1595 - 1606
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sirolimus - therapeutic use | Double-Blind Method | Forced Expiratory Volume - drug effects | Humans | Lymphangioleiomyomatosis - physiopathology | Middle Aged | Lymphangioleiomyomatosis - drug therapy | Sirolimus - blood | TOR Serine-Threonine Kinases - antagonists & inhibitors | Vital Capacity - drug effects | Medication Adherence | Intention to Treat Analysis | Observation | Quality of Life | Adult | Female | Sirolimus - adverse effects | Diagnosis | Drug therapy | Lung diseases | Patient outcomes | Human subjects | Lungs | Kinases | Womens health | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus
Journal Article
The lancet respiratory medicine, ISSN 2213-2600, 08/2013, Volume 1, Issue 6, pp. 445 - 452
Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Biomarkers - metabolism | Lung Neoplasms - drug therapy | Lymphangioleiomyomatosis - blood | Sirolimus - therapeutic use | Prospective Studies | Double-Blind Method | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Lymphangioleiomyomatosis - drug therapy | Vital Capacity - drug effects | Young Adult | Vascular Endothelial Growth Factor D - metabolism | Antibiotics, Antineoplastic - therapeutic use | Adult | Female | Aged | Lung Neoplasms - blood | Index Medicus
Journal Article
Diabetes care, ISSN 0149-5992, 03/2008, Volume 31, Issue 3, pp. 528 - 533
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Glucose Tolerance Test | Prognosis | Blood Glucose - analysis | C-Peptide - blood | Diabetes Mellitus, Type 1 - prevention & control | Autoantibodies - blood | Humans | Middle Aged | Risk Factors | Child, Preschool | Islets of Langerhans - immunology | Diabetes Mellitus, Type 1 - diagnosis | Regression Analysis | Diabetes Mellitus, Type 1 - blood | Adolescent | Adult | Child | Insulin - therapeutic use | Cohort Studies | Autoimmunity | Prevention | Autoantibodies | Type 1 diabetes | Models | Glucose | Research | Dextrose | Intervention | Studies | Hyperglycemia | Diabetes | Health risk assessment | Risk factors | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 08/2019, Volume 381, Issue 7, pp. 603 - 613
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Glucose Tolerance Test | Antibodies, Monoclonal, Humanized - therapeutic use | Diabetes Mellitus, Type 1 - prevention & control | Double-Blind Method | CD3 Complex - antagonists & inhibitors | Humans | Middle Aged | Proportional Hazards Models | Diabetes Mellitus, Type 1 - genetics | Male | Disease Progression | Young Adult | HLA-DR3 Antigen | Exanthema - chemically induced | Adolescent | HLA-DR4 Antigen | Lymphocyte Count | Adult | Female | T-Lymphocytes - immunology | Diabetes Mellitus, Type 1 - immunology | Child | Lymphopenia - chemically induced | Diabetics | Care and treatment | Usage | Safety and security measures | Type 1 diabetes | Monoclonal antibodies | Development and progression | Drug therapy | Risk factors | Laboratories | CD8 antigen | Clinical trials | Lymphocytes T | Diabetes mellitus (insulin dependent) | Glucose | Hyperglycemia | Diagnosis | Drug dosages | Age | Cell survival | Diabetes mellitus | CD3 antigen | Metabolism | Insulin | KLRG1 protein | Immunological tolerance | Zinc transporter | Beta cells | Glucose tolerance | Fc receptors | Lymphopenia | Histocompatibility antigen HLA | Diabetes | Autoimmune diseases | Index Medicus | Abridged Index Medicus
Journal Article
Diabetologia, ISSN 0012-186X, 9/2013, Volume 56, Issue 9, pp. 1919 - 1924
Intermediate endpoints | Prevention | Dysglycaemia | Medicine & Public Health | Human Physiology | HbA 1c | Type 1 diabetes | C-peptide | Metabolic Diseases | Internal Medicine | Clinical trial | HbA | Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Diabetes. Impaired glucose tolerance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Autoantibodies - metabolism | Glucose Tolerance Test | Diabetes Mellitus, Type 1 - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Child, Preschool | Diabetes Mellitus, Type 1 - metabolism | Infant | Male | Young Adult | Diabetes Mellitus, Type 1 - blood | Adolescent | Adult | Female | Blood Glucose - metabolism | C-Peptide - metabolism | Child | Clinical trials | Usage | Index Medicus | HbA1c
Journal Article
Diabetes care, ISSN 0149-5992, 09/2013, Volume 36, Issue 9, pp. 2615 - 2620
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Young Adult | Autoantibodies - immunology | Humans | Risk Factors | Adolescent | Child, Preschool | Adult | Female | Male | Diabetes Mellitus, Type 1 - immunology | Child | Autoimmunity | Diabetics | Care and treatment | Autoantibodies | Type 1 diabetes | Risk factors | Disease prevention | Diabetes | Medical screening | Health risk assessment | Polyclonal antibodies | Predictions | Index Medicus | Original Research
Journal Article
Diabetes care, ISSN 0149-5992, 12/2009, Volume 32, Issue 12, pp. 2269 - 2274
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Diabetes Mellitus, Type 1 - enzymology | Predictive Value of Tests | Receptor-Like Protein Tyrosine Phosphatases, Class 8 - immunology | Prospective Studies | Diabetes Mellitus, Type 1 - prevention & control | Humans | Islets of Langerhans - immunology | Diabetes Mellitus, Type 1 - diagnosis | Autoantibodies - analysis | Surveys and Questionnaires | Diabetes Mellitus, Type 1 - immunology | Glutamate Decarboxylase - immunology | Cohort Studies | Prevention | Autoimmunity | Cell research | Autoantibodies | Type 1 diabetes | Development and progression | Glutamate decarboxylase | Research | Diabetes | Health surveys | Disease prevention | Clinical trials | Pancreas | Index Medicus | Original Research
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9788, pp. 319 - 327
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Double-Blind Method | United States | Humans | Middle Aged | Autoimmune Diseases - immunology | Child, Preschool | Immunotherapy, Active | Male | Diabetes Mellitus, Type 1 - therapy | Young Adult | Canada | Antigens - therapeutic use | Glutamate Decarboxylase - therapeutic use | Adolescent | Autoimmune Diseases - therapy | Antigens - immunology | Female | Diabetes Mellitus, Type 1 - immunology | Glutamate Decarboxylase - immunology | Child | Prevention | Glutamate decarboxylase | Vaccines | Type 1 diabetes | Health aspects | Clinical trials | Data collection | Lines of credit | Diabetes | Pharmaceuticals | Aluminum hydroxide | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9789, pp. 412 - 419
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Diabetes. Impaired glucose tolerance | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Autoimmunity | Insulin-Secreting Cells - physiology | Double-Blind Method | Diabetes Mellitus, Type 1 - physiopathology | Humans | Immunosuppressive Agents - therapeutic use | Male | Diabetes Mellitus, Type 1 - drug therapy | Randomized Controlled Trials as Topic | Immunoconjugates - immunology | Young Adult | Abatacept | Adolescent | Immunoconjugates - therapeutic use | Adult | Female | Immunosuppressive Agents - adverse effects | T-Lymphocytes - immunology | Diabetes Mellitus, Type 1 - immunology | Child | Immunoconjugates - adverse effects | Type 1 diabetes | Physiological aspects | Research | Drug therapy | T cells | Health aspects | Risk factors | Clinical trials | Hepatitis | Diabetes | Peptides | Rheumatoid arthritis | Embargoes & blockades | Index Medicus | Abridged Index Medicus
Journal Article